Table 1.
Logistic Regression Results
Model 1 | Model 2 | |||
---|---|---|---|---|
Parameter | aOR | 95%CI | aOR | 95%CI |
Rural | 0.94 | (0.84, 1.04) | - | - |
25–34 years | 1.12 | (0.77, 1.63) | - | - |
35–44 years | 1.59** | (1.12, 2.27) | 1.47** | (1.15, 1.88) |
45–54 years | 2.13*** | (1.52, 2.98) | 1.95*** | (1.57, 2.44) |
55–64 years | 3.13*** | (2.25, 4.35) | 2.82*** | (2.29, 3.48) |
65–74 years | 4.15*** | (2.98, 5.78) | 3.68*** | (2.97, 4.57) |
75 + years | 5.79*** | (4.16, 8.06) | 4.99*** | (4.02, 6.19) |
Number of Prescribers | 1.13*** | (1.10, 1.17) | 1.15*** | (1.12, 1.18) |
Number of Pharmacies | 1.11*** | (1.06, 1.16) | 1.11*** | (1.06, 1.16) |
Number of Prescriptions | 0.99** | (0.98, 0.99) | - | - |
Opioid-Opioid Overlap | 2.48*** | (2.16, 2.86) | - | - |
LA/SA Opioid Overlap | 2.70*** | (2.32, 3.13) | - | - |
Any Prescription of ER/LA opioid | - | - | 4.41*** | (3.93, 4.94) |
Opioid-Benzodiazepine/Sedative Overlap | 2.13*** | (1.89, 2.39) | - | - |
Any Prescription of Benzodiazepine/Sedative | - | - | 2.50*** | (2.23, 2.79) |
Opioid-Benzo-Carisoprodol Overlap | 1.59* | (1.08, 2.32) | - | - |
Any Prescription of Carisoprodol | - | - | 1.63** | (1.25, 2.13) |
MMEDD >= 90 mg | 1.52*** | (1.25, 1.83) | - | - |
Note.
p<.05,
p<.01,
p<.001;
LA/SA = Long Acting/Short Acting; ER/LA = Extended Release/ Long Acting; MMEDD = Morphine Milligrams Equivalent Daily Dose; aOR = adjusted odds ratio; CI = confidence interval; For complete reporting of regression coefficients see online supplemental tables.